- Top Distributors Lists
- Market Research
- Free Reports
Danaher Corp. (NYSE: DHR), Washington, D.C., has agreed to acquire Beckman Coulter, Inc. (NYSE: BEC), Brea, CA, for approximately $6.8 billion, including debt assumed and net of cash acquired.
Deliver Distribution News to Your Inbox
Sign up below to receive MDM Update, your free weekly distribution news update by email.
With annual revenues of $3.7 billion, Beckman Coulter develops, manufactures and markets products that simplify and automate complex biomedical testing. Its diagnostic systems are used by physicians to diagnose disease, make treatment decisions and monitor patients, and scientists use its life science research instruments to study complex biological problems including causes of disease and potential new therapies or drugs.
Beckman Coulter would become part of Danaher's Life Sciences & Diagnostics segment, joining Danaher's Leica, AB Sciex, Radiometer and Molecular Devices businesses.
Danaher is a diversified technology leader that designs and manufactures products and services to professional, medical, industrial, and commercial customers.